159 related articles for article (PubMed ID: 10732775)
1. Inhibition of apoptosis in human tumour cells by the tumour-associated serpin, SCC antigen-1.
Suminami Y; Nagashima S; Vujanovic NL; Hirabayashi K; Kato H; Whiteside TL
Br J Cancer; 2000 Feb; 82(4):981-9. PubMed ID: 10732775
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of serpin squamous cell carcinoma antigen 2 in human tumor tissues and cell lines: evidence of protection from tumor necrosis factor-mediated apoptosis.
Takeda A; Kajiya A; Iwasawa A; Nakamura Y; Hibino T
Biol Chem; 2002; 383(7-8):1231-6. PubMed ID: 12437110
[TBL] [Abstract][Full Text] [Related]
3. Suppression of a squamous cell carcinoma (SCC)-related serpin, SCC antigen, inhibits tumor growth with increased intratumor infiltration of natural killer cells.
Suminami Y; Nagashima S; Murakami A; Nawata S; Gondo T; Hirakawa H; Numa F; Silverman GA; Kato H
Cancer Res; 2001 Mar; 61(5):1776-80. PubMed ID: 11280721
[TBL] [Abstract][Full Text] [Related]
4. Transient increase in squamous cell carcinoma antigen expression in cultured cervical carcinoma CaSki cells in response to exposure to cis-diamminedichloroplatinum.
Tateiwa Y; Yoshida S; Miyahara Y; Hamana S; Motoyama S; Maruo T
Tumour Biol; 2003; 24(5):219-27. PubMed ID: 15001834
[TBL] [Abstract][Full Text] [Related]
5. Biological role of SCC antigen.
Suminami Y; Nawata S; Kato H
Tumour Biol; 1998; 19(6):488-93. PubMed ID: 9817978
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of transcription factor nuclear factor-kappaB by a mutant inhibitor-kappaBalpha attenuates resistance of human head and neck squamous cell carcinoma to TNF-alpha caspase-mediated cell death.
Duffey DC; Crowl-Bancroft CV; Chen Z; Ondrey FG; Nejad-Sattari M; Dong G; Van Waes C
Br J Cancer; 2000 Nov; 83(10):1367-74. PubMed ID: 11044363
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2.
Nagashima S; Reichert TE; Kashii Y; Suminami Y; Chikamatsu K; Whiteside TL
Cancer Gene Ther; 1997; 4(6):366-76. PubMed ID: 9408607
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterisation of adenoid squamous carcinoma cells highly producing SCC antigen and CEA from carcinoma of the maxillary sinus.
Kishimoto H; Urade M; Sakurai K; Noguchi K
Oral Oncol; 2000 Jan; 36(1):70-5. PubMed ID: 10889923
[TBL] [Abstract][Full Text] [Related]
9. Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen.
Bonfrer JM; Gaarenstroom KN; Korse CM; Van Bunningen BN; Kenemans P
Anticancer Res; 1997; 17(3C):2329-34. PubMed ID: 9245246
[TBL] [Abstract][Full Text] [Related]
10. Utility of squamous cell carcinoma antigen (SCC Ag) as a tumour marker in pulmonary malignancy.
Upham J; Campbell B
Respir Med; 1992 May; 86(3):201-3. PubMed ID: 1620906
[TBL] [Abstract][Full Text] [Related]
11. Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma.
Shimada H; Nabeya Y; Okazumi S; Matsubara H; Shiratori T; Gunji Y; Kobayashi S; Hayashi H; Ochiai T
Surgery; 2003 May; 133(5):486-94. PubMed ID: 12773976
[TBL] [Abstract][Full Text] [Related]
12. Squamous cell carcinoma antigen suppresses radiation-induced cell death.
Murakami A; Suminami Y; Hirakawa H; Nawata S; Numa F; Kato H
Br J Cancer; 2001 Mar; 84(6):851-8. PubMed ID: 11259103
[TBL] [Abstract][Full Text] [Related]
13. Role of squamous cell carcinoma antigen 1 expression in the invasive potential of head and neck squamous cell carcinoma.
Nakashima T; Yasumatsu R; Kuratomi Y; Masuda M; Kuwano T; Toh S; Umezaki T; Cataltepe S; Silverman GA; Komune S
Head Neck; 2006 Jan; 28(1):24-30. PubMed ID: 16155915
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of serum squamous cell carcinoma antigen in patients with head and neck cancer.
Imai R; Takenaka Y; Yasui T; Nakahara S; Yamamoto Y; Hanamoto A; Takemoto N; Fukusumi T; Cho H; Yamamoto M; Inohara H
Acta Otolaryngol; 2015 Mar; 135(3):295-301. PubMed ID: 25622661
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis of recurrences of head and neck carcinoma with the tumor marker SSC-antigen].
Arlt A; Luckhaupt H; Hildmann H
Laryngorhinootologie; 2000 Apr; 79(4):207-12. PubMed ID: 10838684
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of serum squamous cell carcinoma antigen in surgically treated lung cancer.
Takeuchi S; Nonaka M; Kadokura M; Takaba T
Ann Thorac Cardiovasc Surg; 2003 Apr; 9(2):98-104. PubMed ID: 12732086
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of serum SCC Ag in patients with squamous cell carcinoma of the lung].
Zeng L
Zhonghua Wai Ke Za Zhi; 1993 Mar; 31(3):143-5. PubMed ID: 8223022
[TBL] [Abstract][Full Text] [Related]
18. [Clinical study on the measurement of squamous cell carcinoma (SCC)--related antigen in SCC].
Fukunaga M; Otsuka N; Sone T; Nagai K; Muranaka A; Furukawa T; Yanagi M; Yanagimoto S; Tomomitsu T; Morita R
Gan No Rinsho; 1985 Dec; 31(15):1885-8. PubMed ID: 3842935
[TBL] [Abstract][Full Text] [Related]
19. The predictive value of serum squamous cell carcinoma antigen in patients with cervical cancer who receive neoadjuvant chemotherapy followed by radical surgery: a single-institute study.
Li X; Zhou J; Huang K; Tang F; Zhou H; Wang S; Jia Y; Sun H; Ma D; Li S
PLoS One; 2015; 10(4):e0122361. PubMed ID: 25860888
[TBL] [Abstract][Full Text] [Related]
20. The C-D interhelical domain of the serpin plasminogen activator inhibitor-type 2 is required for protection from TNF-alpha induced apoptosis.
Dickinson JL; Norris BJ; Jensen PH; Antalis TM
Cell Death Differ; 1998 Feb; 5(2):163-71. PubMed ID: 10200461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
